ArticleFrontiers in pharmacology2023

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy.

Claudia Arndt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.